A detailed history of Redwood Investments, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Redwood Investments, LLC holds 120,136 shares of NEO stock, worth $1.63 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
120,136
Previous 148,264 18.97%
Holding current value
$1.63 Million
Previous $2.4 Million 21.27%
% of portfolio
0.5%
Previous 0.63%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$14.06 - $16.79 $395,479 - $472,269
-28,128 Reduced 18.97%
120,136 $1.89 Million
Q4 2023

Jan 19, 2024

BUY
$11.67 - $20.73 $1.73 Million - $3.07 Million
148,264 New
148,264 $2.4 Million
Q1 2022

Apr 20, 2022

SELL
$12.15 - $35.28 $4.07 Million - $11.8 Million
-335,054 Closed
0 $0
Q4 2021

Feb 03, 2022

SELL
$30.49 - $48.49 $99,275 - $157,883
-3,256 Reduced 0.96%
335,054 $11.4 Million
Q3 2021

Oct 19, 2021

SELL
$41.66 - $52.52 $843,406 - $1.06 Million
-20,245 Reduced 5.65%
338,310 $16.3 Million
Q2 2021

Aug 02, 2021

SELL
$36.62 - $51.69 $206,207 - $291,066
-5,631 Reduced 1.55%
358,555 $16.2 Million
Q1 2021

May 17, 2021

SELL
$41.56 - $59.88 $2.43 Million - $3.5 Million
-58,434 Reduced 13.83%
364,186 $17.6 Million
Q4 2020

Feb 05, 2021

SELL
$36.08 - $56.47 $2.07 Million - $3.24 Million
-57,454 Reduced 11.97%
422,620 $22.8 Million
Q3 2020

Nov 13, 2020

SELL
$33.26 - $40.48 $819,626 - $997,548
-24,643 Reduced 4.88%
480,074 $17.7 Million
Q2 2020

Aug 03, 2020

BUY
$24.21 - $31.02 $192,203 - $246,267
7,939 Added 1.6%
504,717 $15.6 Million
Q1 2020

May 06, 2020

SELL
$20.5 - $34.53 $2.07 Million - $3.49 Million
-101,123 Reduced 16.91%
496,778 $13.7 Million
Q4 2019

Feb 04, 2020

BUY
$18.96 - $29.84 $11.3 Million - $17.8 Million
597,901 New
597,901 $17.5 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.71B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Redwood Investments, LLC Portfolio

Follow Redwood Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redwood Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redwood Investments, LLC with notifications on news.